Matthew Paul Kowalsky
CIK 1705824 · Chief Legal Officer · last filed 2026-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$880.5K
Companies
3
Total Filings
12
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTA | Chief Legal Officer | 5,493 | $11.90 | $65.4K | $0 | 4 | 2026-02-13 |
| Sigilon Therapeutics, Inc. (SGTX) Delisted | CHIEF OF STAFF AND CLO | 0 | $22.47 | $0 | $0 | 2 | 2023-08-11 |
| PRTO | VP, Legal and Secretary | 29,479 | $27.65 | $815.2K | $0 | 6 | 2019-01-23 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-01-03 | PRTO | Grant (A) | +3,934 | $5.1K | EDGAR |
| 2017-07-05 | PRTO | Grant (A) | +10,000 | $13.0K | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.